Cost Burdens on Patients Older than 66 with Oral Cavity, Pharyngeal Cancers

Share this content:

the Cancer Therapy Advisor take:

Several factors including demographics, comorbidities, and treatment selection are associated with the burdensome Medicare cost of oral and pharyngeal cancer in older patients, according to an article published online in the journal JAMA Otolaryngology—Head & Neck Surgery.

Participants in this study included patients 66 and older with newly diagnosed oral cavity (n = 6,724) and pharyngeal (n = 3,987) cancers between January 1, 1995, and December 31, 2005.

Results showed demographics, comorbidities, and treatment types were all associated with a significant cost increase. African Americans accumulated $11,450 (95% CI: $1,320, $22,299) more in costs for oral cavity cancer and $25,093 (95% CI: $14,917 - $ 34,985) more in costs for pharyngeal cancer.

The mean 5-year cumulative costs for patients with the presence of one or two comorbidities and oral cavity cancer increased by $13,342 (95% CI: $6248, $19,186) and $14,139 (95% CI: $6,009, $22,217) for those with pharyngeal cancer. With the presence of three or more comorbidities, the mean 5-year cumulative costs for patients with oral cavity cancer increased by $22,196 (95% CI: $15,319, $28,614), while an increase of $27,799 (95% CI: $19,139, $36,702) was observed for patients with pharyngeal cancer.

Patients with oral cavity and pharyngeal cancers who received chemotherapy accrued a mean of $26,919 (95% CI: $18,309, $35,056) and $37,407 (95% CI: $29,971, $44,644) more in Medicare costs by 5 years.

Elective neck dissection in clinically node-negative early oral squamous cell carcinoma should be co
Several factors associated with the burdensome Medicare cost of oral and pharyngeal cancer in older patients.
In the United States, nearly 8400 patients die each year from oral cavity and pharynx cancers, most of whom are 65 years and older; however, the costs attributable to these cancers are not well described.
READ FULL ARTICLE From archotol.jamanetwork.com

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters